Cargando…

Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis

BACKGROUND: To summarize the chemo-radio effect of metformin in rectal cancers with neoadjuvant chemoradiotherapy on pathological response, tumor regression grade (TRG), and T/N downstaging. METHODS: PubMed, MEDLINE, Embase, and Cochrane Database of collected reviews were searched up to June 30, 202...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, I-Li, You, Jeng-Fu, Tsai, Wen-Sy, Hsu, Yu-Jen, Chern, Yih-Jong, Wu, Ming-Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369710/ https://www.ncbi.nlm.nih.gov/pubmed/37491250 http://dx.doi.org/10.1186/s12957-023-03087-6

Ejemplares similares

Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
por: Hsu, Yu-Jen, et al.
Publicado: (2022)

The risk factors of local recurrence and distant metastasis on pT1/T2N0 mid-low rectal cancer after total mesorectal excision
por: Lai, I-Li, et al.
Publicado: (2021)

Potential short-term outcome advantage of low vs. high ligation of inferior mesenteric artery for sigmoid and rectal cancer: propensity score matching analysis
por: Hsu, Chia-Chen, et al.
Publicado: (2023)

Neoadjuvant Short-Course Radiotherapy Followed by Consolidation Chemotherapy before Surgery for Treating Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis
por: Liao, Chun-Kai, et al.
Publicado: (2022)

Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk
por: Lai, I-Li, et al.
Publicado: (2019)

Neoadjuvant therapy of metformin is associated with good tumor response after preoperative concurrent chemoradiotherapy for rectal cancer
por: Han, Jeonghee, et al.
Publicado: (2022)

Neoadjuvant Chemoradiotherapy Does Not Contribute to Worse Survival in Pathological Node-Negative Rectal Cancer
por: Huang, Yong, et al.
Publicado: (2021)

Predictive Factors for Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer
por: Zhang, Qi, et al.
Publicado: (2021)

Clinical prediction model of pathological response following neoadjuvant chemoradiotherapy for rectal cancer
por: Shin, Jung Kyong, et al.
Publicado: (2022)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
por: Lin, Huaqin, et al.
Publicado: (2021)

Restaging rectal cancer following neoadjuvant chemoradiotherapy
por: Cuicchi, Dajana, et al.
Publicado: (2023)

Improvement of ulcerative colitis control by searching and restricting of inflammatory trigger factors in daily clinical practice
por: Tsai, Kun-Yu, et al.
Publicado: (2023)

Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer
por: Zeng, Wei-Gen, et al.
Publicado: (2015)

Morphologic predictors of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Zhang, Chongda, et al.
Publicado: (2017)

Local environment in biopsy better predict the pathological response to neoadjuvant chemoradiotherapy in rectal cancer
por: Huang, Yan, et al.
Publicado: (2019)

Machine learning for predicting pathological complete response in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy
por: Huang, Chun-Ming, et al.
Publicado: (2020)

Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy
por: Wen, Bixiu, et al.
Publicado: (2015)

Apparent Diffusion Coefficient Predicts Pathology Complete Response of Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
por: Chen, Yuan-Gui, et al.
Publicado: (2016)

Do pathological variables have prognostic significance in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and surgery?
por: Reggiani Bonetti, Luca, et al.
Publicado: (2017)

Patterns of recurrence in patients achieving pathologic complete response after neoadjuvant chemoradiotherapy for rectal cancer
por: Fan, Wen-Hua, et al.
Publicado: (2017)

Obesity may not be related to pathologic response in locally advanced rectal cancer following neoadjuvant chemoradiotherapy
por: Bao, Quoc Riccardo, et al.
Publicado: (2022)

Advantage of laparoscopy surgery for elderly colorectal cancer patients without compromising oncologic outcome
por: Chern, Yih-Jong, et al.
Publicado: (2020)

An Immune-Related Gene Signature for Predicting Neoadjuvant Chemoradiotherapy Efficacy in Rectal Carcinoma
por: Qian, Liwen, et al.
Publicado: (2022)

Efficient and Safe Method for Splenic Flexure Mobilization in Laparoscopic Left Hemicolectomy: A Propensity Score–weighted Cohort Study
por: Hsu, Yu-Jen, et al.
Publicado: (2020)

Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients
por: Mei, Shi-Wen, et al.
Publicado: (2020)

Analysis of Clinical characteristics to predict pathologic complete response for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
por: Peng, Haihua, et al.
Publicado: (2018)

Pathological Assessment of Rectal Cancer after Neoadjuvant Chemoradiotherapy: Distribution of Residual Cancer Cells and Accuracy of Biopsy
por: Xiao, Lin, et al.
Publicado: (2016)

Assessment of clinical and pathological complete response after neoadjuvant chemoradiotherapy in rectal adenocarcinoma and its therapeutic implications
por: Alexandrescu, Sorin Tiberiu, et al.
Publicado: (2021)

Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer
por: Lou, Xiaoying, et al.
Publicado: (2022)

Prognostic value of regional lymph node involvement in patients with metastatic colorectal cancer: palliative versus curative resection
por: Kuo, Ya-Ting, et al.
Publicado: (2021)

The Nuts and Bolts of Implementing a Modified ERAS Protocol for Minimally Invasive Colorectal Surgery: Group Practice vs. Solo Practice
por: Yu, Zhen-Hao, et al.
Publicado: (2022)

Advantage of laparoscopic surgery in patients with generalized obesity operated for colorectal malignancy: A retrospective cohort study
por: Yu, Yen-Lin, et al.
Publicado: (2023)

A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: Li, Yi, et al.
Publicado: (2016)

Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Kawai, Kazushige, et al.
Publicado: (2018)

Neoadjuvant FOLFIRINOX followed by Chemoradiotherapy for Middle and Lower Rectal Cancer
por: Sakr, Amr, et al.
Publicado: (2020)

Predictors and Risk Factors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Population-Based Analysis
por: Tan, Yinuo, et al.
Publicado: (2019)

High Expression of Aldolase B Confers a Poor Prognosis for Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy
por: Tian, Yu-Feng, et al.
Publicado: (2017)

Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis: Oxaliplatin in neoadjuvant treatment for rectal cancer
por: De Felice, Francesca, et al.
Publicado: (2017)

Clinical significance of adjuvant chemotherapy for pathological complete response rectal cancer patients with acellular mucin pools after neoadjuvant chemoradiotherapy
por: Chen, Mian, et al.
Publicado: (2023)

Preoperative Cancer Inflammation Prognostic Index as a Superior Predictor of Short- and Long-Term Outcomes in Patients with Stage I–III Colorectal Cancer after Curative Surgery
por: You, Jeng-Fu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7d84ckddmrlajh2ofa7k8elqgd